Holen Sie sich die Stockscreener-App
104.80
4.22%
-4.44
Schlusskurs vom Vortag:
$109.24
Offen:
$108.17
24-Stunden-Volumen:
110.98K
Relative Volume:
0.14
Marktkapitalisierung:
$2.66B
Einnahmen:
$302.00K
Nettoeinkommen (Verlust:
$-117.10M
KGV:
-9.416
EPS:
-11.13
Netto-Cashflow:
$-129.13M
1W Leistung:
+4.65%
1M Leistung:
+2.59%
6M Leistung:
+382.39%
1J Leistung:
+699.32%
1-Tages-Spanne:
$104.20
$109.37
1-Wochen-Bereich:
$98.25
$113.00
52-Wochen-Spanne:
$12.74
$121.21
Cidara Therapeutics Inc Stock (CDTX) Company Profile
Firmenname
Cidara Therapeutics Inc
Sektor
Branche
Telefon
858-752-6170
Adresse
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Vergleichen Sie CDTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
104.79 | 2.77B | 302.00K | -117.10M | -129.13M | -11.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.68 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
827.86 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.35 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-10 | Eingeleitet | JP Morgan | Overweight |
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-12 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-01-27 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2024-12-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-11-08 | Eingeleitet | Guggenheim | Buy |
| 2024-08-14 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-09-22 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | Eingeleitet | Aegis Capital | Buy |
| 2019-09-04 | Hochstufung | Wedbush | Neutral → Outperform |
| 2018-07-26 | Eingeleitet | Citigroup | Buy |
| 2017-04-21 | Eingeleitet | Raymond James | Strong Buy |
| 2017-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2017-04-12 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-04-11 | Fortgesetzt | Wedbush | Outperform |
| 2017-02-22 | Bestätigt | H.C. Wainwright | Buy |
| 2017-02-22 | Hochstufung | WBB Securities | Sell → Hold |
| 2016-12-21 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-12-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-09-23 | Herabstufung | WBB Securities | Hold → Sell |
| 2015-10-09 | Hochstufung | WBB Securities | Sell → Hold |
| 2015-05-11 | Eingeleitet | Jefferies | Buy |
| 2015-05-11 | Eingeleitet | Leerink Partners | Outperform |
| 2015-05-11 | Eingeleitet | Needham | Buy |
| 2015-05-11 | Eingeleitet | Wedbush | Outperform |
| 2015-04-23 | Eingeleitet | WBB Securities | Sell |
Alle ansehen
Cidara Therapeutics Inc Aktie (CDTX) Neueste Nachrichten
Signal strength of Cidara Therapeutics Inc. stock in tech scannersStock Surge & AI Driven Price Predictions - newser.com
Using data models to predict Cidara Therapeutics Inc. stock movementJuly 2025 News Drivers & Accurate Trade Setup Notifications - newser.com
Does Cidara Therapeutics Inc. stock trade at a discount to peersRecession Risk & Low Risk Entry Point Tips - newser.com
AlphaQuest LLC Makes New Investment in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Jennison Associates LLC Invests $2.40 Million in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Should you hold or exit Cidara Therapeutics Inc. nowMarket Rally & Fast Exit Strategy with Risk Control - newser.com
How Cidara Therapeutics Inc. stock benefits from strong dollarNew Guidance & Free Technical Pattern Based Buy Signals - newser.com
What to do if you’re stuck in Cidara Therapeutics Inc.July 2025 Momentum & AI Powered Market Trend Analysis - newser.com
Cidara Therapeutics (CDTX): Assessing Valuation After FDA Breakthrough Therapy Nod and New BARDA Support - Sahm
Cidara Therapeutics (CDTX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
What hedge fund moves indicate for Cidara Therapeutics Inc. (20D0) stockEarnings Summary Report & Daily Stock Momentum Reports - newser.com
Published on: 2025-10-31 05:10:02 - newser.com
How Cidara Therapeutics Inc. stock compares to growth peersWeekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Cidara Therapeutics Inc. stock outperform international peers2025 Big Picture & Safe Entry Momentum Tips - newser.com
Why Cidara Therapeutics Inc. stock is in analyst buy zone2025 Bull vs Bear & Consistent Income Trade Recommendations - newser.com
Will Cidara Therapeutics Inc. stock deliver long term returns2025 Pullback Review & Reliable Price Breakout Alerts - newser.com
How to escape a deep drawdown in Cidara Therapeutics Inc.2025 Historical Comparison & Stock Portfolio Risk Management - newser.com
Is Cidara Therapeutics Inc. forming a bottoming base2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
Using Ichimoku Cloud for Cidara Therapeutics Inc. technicalsJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com
Cidara Therapeutics (CDTX) Price Target Increased by 24.94% to 167.79 - Nasdaq
How risky is Cidara Therapeutics Inc. stock now2025 Volatility Report & Low Drawdown Momentum Trade Ideas - newser.com
Cidara Therapeutics (NASDAQ:CDTX) Trading 8.2% HigherHere's What Happened - MarketBeat
Cidara Therapeutics to Participate in November Investor Conferences - The Manila Times
Finanzdaten der Cidara Therapeutics Inc-Aktie (CDTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.21%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):